# Correction: GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease

**Authors:** Stephan Sachs, Anna Götz, Brian Finan, Annette Feuchtinger, Richard D. DiMarchi, Yvonne Döring, Christian Weber, Matthias H. Tschöp, Timo D. Müller, Susanna M. Hofmann

PMC · DOI: 10.1186/s12933-024-02407-8 · Cardiovascular Diabetology · 2024-09-12

## Full-text entities

- **Diseases:** atherosclerosis (MESH:D050197), dyslipidemia (MESH:D050171), cardio-metabolic disease (MESH:D008659), weight loss (MESH:D015431)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11395572/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11395572/full.md

---
Source: https://tomesphere.com/paper/PMC11395572